Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Inclusion Criteria:

- Pathologically proven diagnosis of ovarian carcinoma, fallopian tube, or primary
peritoneal not to include tumors of low malignant potential (all stage, grade, and
histology)

- First recurrence

- Platinum sensitive as defined by disease free interval ≥ 6 months

- Radiological evidence of recurrent disease on preoperative PET/diagnostic CT

- Planned surgical secondary cytoreduction via laparotomy

- >18 years old

Exclusion Criteria:

- Secondary cytoreduction via laparoscopy or robotically assisted laparoscopy

- Tumors of low malignant potential

- Beyond first recurrence

- With the exception of non-melanoma skin cancer, subjects with other invasive
malignancies, who had (or have) any evidence of the other cancer present within the
last 5 years, are excluded

- Active infection requiring parenteral antibiotics

- For subjects with diabetes mellitus, a blood sugar will be checked preoperatively and
must be <200 for participation in the study